BBH — Bellevue Healthcare Trust Income Statement
0.000.00%
Last trade - 00:00
FinancialsBalancedMid Cap
- £680.49m
- £601.23m
- -£107.95m
2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | 2023 November 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 51.2 | 167 | 99.3 | -27.6 | -108 |
Cost of Revenue | |||||
Gross Profit | 45.9 | 160 | 89.4 | -37.2 | -116 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.97 | 7.67 | 10.8 | 10.5 | 8.88 |
Operating Profit | 45.2 | 160 | 88.4 | -38.1 | -117 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 43.1 | 158 | 87.9 | -41.1 | -121 |
Provision for Income Taxes | |||||
Net Income After Taxes | 42.8 | 158 | 87.3 | -41.4 | -121 |
Net Income Before Extraordinary Items | |||||
Net Income | 42.8 | 158 | 87.3 | -41.4 | -121 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 42.8 | 158 | 87.3 | -41.4 | -121 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.108 | 0.347 | 0.165 | -0.071 | -0.221 |
Dividends per Share |